细胞药物的研发现状——细胞药物 连载之三

The Current Research and Development Status of Cell Drug

近年来,细胞药物的研究受到了国内外重视。特别是干细胞药物,已成为世界各国竞相研究的热点领域,但各国的干细胞药物绝大多数仍处于研究阶段,全球真正上市的干细胞药物很少。目前正在研发的干细胞药物主要集中在治疗慢性疾病(关节炎、糖尿病和癌症等)和心脏相关疾病(心肌梗死、心脏衰竭等)。一些传统体细胞药物(软骨细胞、心肌细胞、胰岛细胞等)和免疫细胞药物已在临床应用。

In recent years, the research of cell drug has been paid more attention at home and abroad. Stem cell drug, in particular, has become a hot research field around the world. The vast majority of stem cell drugs in various countries are still in the research stage, and only a few of stem cell drugs have come into the market. The currently developing stem cell drugs are focused on the treatment of chronic diseases （ arthritis, diabetes and cancer, etc. ） and heart related diseases （myocardial infarction, heart failure, etc. ）. Some traditional somatic cell drugs （such as chondrocytes, cardiac muscle cells, islet cells, etc. ） and immune cell drugs have already been used in clinic.